Oto

Emerging

London digital CBT app for tinnitus with DEFINE Trial evidence showing 86% benefit in one month; £2.8M seed competing with Widex and ReSound for 750M global tinnitus sufferers needing accessible specialist care.

Company Overview

About Oto

Oto is a London-based digital health company providing clinically validated, app-based CBT (cognitive behavioral therapy) treatment for tinnitus — the persistent ringing, buzzing, or hissing in the ears that affects 15% of the global population (750 million+ people) with no pharmaceutical cure — delivering structured therapeutic programs designed by tinnitus specialists that help patients manage and reduce tinnitus distress through evidence-based psychological and sound therapy techniques. Founded and backed with £2.8 million in seed funding raised in 2022, Oto demonstrated in the DEFINE Trial (the largest randomized controlled trial for any digital tinnitus program) that 86% of users experience measurable benefits within one month of the program.

Business Model & Competitive Advantage

Oto's therapeutic model is grounded in Tinnitus Retraining Therapy (TRT) and CBT — the gold standard clinical approaches that retrain the brain's response to tinnitus sound rather than attempting to eliminate the sound itself. The app-based delivery makes TRT and CBT accessible without specialist referrals: traditional tinnitus CBT requires sessions with a specialized audiologist or psychologist (typically 6-12 sessions at £100-200 each), limiting access to patients in major cities with specialist waitlists. Oto's structured 8-week program delivers the same therapeutic framework through daily app exercises, educational content about tinnitus neuroscience, sound therapy (white noise, nature sounds, notched audio therapy), and mood and symptom tracking.

Competitive Landscape 2025–2026

In 2025, Oto competes in the digital tinnitus and hearing health market with Widex Sound Relief (hearing aid manufacturer's tinnitus app), Neuromod Lenire (bimodal neuromodulation device for tinnitus, €100M raised), and ReSound Relief (GN Audio tinnitus management app) for tinnitus patient engagement and clinical validation. The NHS Long Term Plan for digital first care creates NHS partnership opportunities for Oto as a NICE-approved digital therapeutic. US expansion (planned for 2025) accesses the 50 million Americans with tinnitus who lack adequate clinical care options. The 2025 strategy focuses on NHS commissioning partnerships (prescribable digital therapeutic), US audiologist partnerships for clinical referral networks, and building the enterprise hearing health benefit channel for employers in high-noise industries (manufacturing, construction, military).

Revenue
$2.8M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Oto is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Not So Random Others

Zeffy

Nonprofit Tech
B2bSaas

Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs

Oda Studio

Real Estate & Property Tech
B2bProptechAi PoweredSaas

Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Cursor

Developer Tools & Platforms
B2bDeveloper ToolsSaasUnicorn

Cursor is an AI-powered code editor built on Visual Studio Code that integrates advanced language models to provide intelligent code completion, generation, debugging, and refactoring capabilities dir

Kindful

Nonprofit Tech
B2bSaasSmb

Kindful is a donor management and fundraising platform designed for nonprofit organizations to manage relationships, track donations, and execute fundraising campaigns. The company serves small to mid

Compare Oto with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Oto

Claim This Profile

Are you from Oto? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Oto Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Oto vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →